Covered recipient · General Payments record
SAMANTHA RENEE PHILLIPS
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2022–2024
$1,896.53
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $584.93 | 17 |
| Education | $82.95 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $253.79 | 7 |
| GENZYME CORPORATION | $145.56 | 4 |
| Janssen Biotech, Inc. | $82.95 | 1 |
| Lilly USA, LLC | $81.36 | 3 |
| Merz Pharmaceuticals, LLC | $43.25 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $42.59 | 1 |
| Biofrontera Inc. | $18.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.91 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103955506 | CMS |
| ABBVIE INC. | $33.69 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103955508 | CMS |
| ABBVIE INC. | $20.67 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103955510 | CMS |
| ABBVIE INC. | $21.47 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103955512 | CMS |
| ABBVIE INC. | $18.69 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103955514 | CMS |
| ABBVIE INC. | $115.56 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103955516 | CMS |
| ABBVIE INC. | $20.80 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103955518 | CMS |
| Biofrontera Inc. | $18.38 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105924978 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $42.59 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117942785 | CMS |
| GENZYME CORPORATION | $35.87 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139677809 | CMS |
| GENZYME CORPORATION | $39.08 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139677835 | CMS |
| GENZYME CORPORATION | $37.25 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139677875 | CMS |
| GENZYME CORPORATION | $33.36 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139677949 | CMS |
| Janssen Biotech, Inc. | $82.95 | 11/08/2024 | Education | Undisputed | 01/23/2026 | 1078581953 | CMS |
| Lilly USA, LLC | $27.50 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135371467 | CMS |
| Lilly USA, LLC | $29.11 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135387373 | CMS |
| Lilly USA, LLC | $24.75 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135401239 | CMS |
| Merz Pharmaceuticals, LLC | $43.25 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137954506 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.